Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07038124 ointment in mild to moderate atopic dermatitis or plaque psoriasis
2020-003977-23Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) and plaque psoriasis comparing PF-07038124 ointment with Vehicle (placebo) ointment (2 arms). Primary endpoints: Primary efficacy endpoint for atopic dermatitis, Safety and tolerability and 1 more. Started Nov 2020; status: completed.
02
Drugs
PF-07038124
03
Conditions
atopic dermatitis (AD)plaque psoriasis
Beyond the preview
Go deeper on 2020-003977-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003977-23.